Insider Trading Activity Opko Health Inc. (NASDAQ:OPK) – CEO Bought 185,000 shares of Stock

ME Staff

7 years ago

Insider Trading Activity For Opko Health Inc. (NASDAQ:OPK)

Phillip Md Et Al Frost , CEO of Opko Health Inc. (NASDAQ:OPK) reportedly Bought 185,000 shares of the company’s stock at an average price of 3.83 for a total transaction amount of $708,550.00 SEC Form

Insider Trading History For Opko Health Inc. (NASDAQ:OPK)

On 8/6/2012 Phillip Md Et Al Frost, Director, bought 115,000 with an average share price of $4.29 per share and the total transaction amounting to $493,350.00.

On 8/7/2012 Phillip Md Et Al Frost, Director, bought 50,000 with an average share price of $4.27 per share and the total transaction amounting to $213,500.00.

On 8/8/2012 Phillip Md Et Al Frost, Director, bought 47,500 with an average share price of $4.25 per share and the total transaction amounting to $201,875.00.

On 8/9/2012 Phillip Md Et Al Frost, Director, bought 70,000 with an average share price of $4.24 per share and the total transaction amounting to $296,800.00.

On 8/10/2012 Phillip Md Et Al Frost, Director, bought 100,000 with an average share price of $4.24 per share and the total transaction amounting to $424,000.00.

On 8/13/2012 Phillip Md Et Al Frost, Director, bought 60,000 with an average share price of $4.22 per share and the total transaction amounting to $253,200.00.

On 8/14/2012 Phillip Md Et Al Frost, Director, bought 45,000 with an average share price of $4.18 per share and the total transaction amounting to $188,100.00.

Analyst Ratings History For Opko Health Inc. (NASDAQ:OPK)

On 6/16/2016 Deutsche Bank Lower Price Target of rating Hold with a price target of $11.00 to $10.00
On 10/10/2016 Oppenheimer Reiterated Rating Hold
On 1/3/2017 Laidlaw Reiterated Rating Buy with a price target of $22.00 to $19.00
On 3/5/2017 Standpoint Research Reiterated Rating Buy with a price target of $14.00
On 3/14/2017 Guggenheim Initiated Coverage of rating Buy with a price target of $25.00
On 7/18/2017 Barrington Research Boost Price Target of rating Outperform with a price target of $11.00
On 8/10/2017 Jefferies Group Reiterated Rating Hold with a price target of $6.80 to $6.50

Recent Trading Activity for Opko Health Inc. (NASDAQ:OPK)
Shares of Opko Health Inc. closed the previous trading session at 3.88 +0.00 0.00% with 4.090000152587891 shares trading hands.